These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 7906803)

  • 1. Recombinant hepatitis B vaccine immunogenicity in presence of hepatitis C virus seropositivity.
    Kamel M; el Manialawi M; Miller FD
    Lancet; 1994 Feb; 343(8896):552. PubMed ID: 7906803
    [No Abstract]   [Full Text] [Related]  

  • 2. Hepatitis B vaccine, hepatitis C virus infection, and haemodialysis.
    Navarro JF; Teruel JL
    Lancet; 1995 Sep; 346(8978):845. PubMed ID: 7674769
    [No Abstract]   [Full Text] [Related]  

  • 3. Response to hepatitis B virus vaccination in haemodialysis patients with and without hepatitis C infection.
    Sorkhi H; Roushan MR; Al Hashemi GH; Dooki MR; Bai S
    East Mediterr Health J; 2008; 14(4):798-803. PubMed ID: 19166162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors affecting responsiveness to hepatitis B immunization in dialysis patients.
    Asan A; Demirhan H; Sorkun HÇ; Özkan S; Aydın M; Akın D; Tatar B; Çatak B; Şener A; Köse Ş
    Int Urol Nephrol; 2017 Oct; 49(10):1845-1850. PubMed ID: 28620716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-responsiveness to hepatitis B vaccination in HIV seropositive patients; possible causes and solutions.
    van den Berg R; van Hoogstraten I; van Agtmael M
    AIDS Rev; 2009; 11(3):157-64. PubMed ID: 19654857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis C virus and the immunological response to hepatitis B virus vaccine in dialysis patients: meta-analysis of clinical studies.
    Fabrizi F; Dixit V; Martin P; Messa P
    J Viral Hepat; 2011 Dec; 18(12):871-6. PubMed ID: 22093033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Safety and immunogenicity of an anti-hepatitis-B vaccine obtained using the recombinant DNA technique: results of a longitudinal study in hospital personnel].
    Ricciardi G; Graziano G
    Boll Ist Sieroter Milan; 1990 Jun; 69(2):385-90. PubMed ID: 2152297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis C virus infection decreases the effective antibody response to hepatitis B vaccine in hemodialysis patients.
    Navarro JF; Teruel JL; Mateos M; Ortuño J
    Clin Nephrol; 1994 Feb; 41(2):113-6. PubMed ID: 8004827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenicity, effectiveness and safety of combined hepatitis A and B vaccine: a systematic literature review.
    Bakker M; Bunge EM; Marano C; de Ridder M; De Moerlooze L
    Expert Rev Vaccines; 2016 Jul; 15(7):829-51. PubMed ID: 26840060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenicity of an accelerated vaccination regime with a combined hepatitis a/b vaccine in patients with chronic hepatitis C.
    Kallinowski B; Jilg W; Buchholz L; Stremmel W; Engler S
    Z Gastroenterol; 2003 Oct; 41(10):983-90. PubMed ID: 14562195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccination against hepatitis B and C: towards therapeutic application.
    Inchauspe G; Bach G; Martin P; Bonnefoy JY
    Int Rev Immunol; 2009; 28(1):7-19. PubMed ID: 19241251
    [No Abstract]   [Full Text] [Related]  

  • 12. Hepatitis B vaccine: Immunogenicity in an extremely low-birthweight infant.
    Yamana K; Iwatani S; Fujioka K; Iijima K; Morioka I
    Pediatr Int; 2018 May; 60(5):489-490. PubMed ID: 29878632
    [No Abstract]   [Full Text] [Related]  

  • 13. Risk factors for lack of detectable antibody following hepatitis B vaccination of Minnesota health care workers.
    Wood RC; MacDonald KL; White KE; Hedberg CW; Hanson M; Osterholm MT
    JAMA; 1993 Dec 22-29; 270(24):2935-9. PubMed ID: 8254853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Epidemiological aspects of viral hepatitis: immunogenicity of hepatitis B vaccine administered to children and adolescents].
    del Rey Calero J
    An R Acad Nac Med (Madr); 1992; 109(2):261-96; discussion 296-8. PubMed ID: 1463144
    [No Abstract]   [Full Text] [Related]  

  • 15. [Viral markers of hepatitis B, C and D and HB vaccination status of a health care team in a rural district of Cameroon].
    Birguel J; Ndong JG; Akhavan S; Moreau G; Sobnangou JJ; Aurenche C; Lunel F; Thibault V; Huraux JM
    Med Trop (Mars); 2011 Apr; 71(2):201-2. PubMed ID: 21695887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenicity of hepatitis B vaccine in multi-transfused thalassemic patients with and without hepatitis C infection: a comparative study with healthy controls.
    Froutan-Pishbijari H; Ghofrani H; Mirmomenm S; Kazemi-Asl S; Nassiri-Toosi M; Farahvash MJ; Toroghi HH; Aminian K; Mansour-Ghanaei F; Bagherzadeh AH
    Med Sci Monit; 2004 Dec; 10(12):CR679-83. PubMed ID: 15567986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody responses to intradermal recombinant hepatitis B immunization among HIV-positive subjects.
    Ristola MA; Vuola JM; Valle M; von Reyn CF
    Vaccine; 2004 Nov; 23(2):205-9. PubMed ID: 15531038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis B virus vaccine in chronic kidney disease: improved immunogenicity by adjuvants? A meta-analysis of randomized trials.
    Fabrizi F; Dixit V; Messa P; Martin P
    Vaccine; 2012 Mar; 30(13):2295-300. PubMed ID: 22285268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenicity of a low dose of indigenously developed recombinant hepatitis-B vaccine in neonates and infants.
    Rao MN; Joshi N; Habibullah CM
    Indian Pediatr; 1999 Jun; 36(6):581-3. PubMed ID: 10736587
    [No Abstract]   [Full Text] [Related]  

  • 20. [The characteristics of the epidemic process in hepatitis B, C and D in hemodialysis units and the experience of the vaccinal prevention of HB viral infection in a delimited population].
    Savin EA; Vasil'ev AN; Paskonkina OV; Os'mirko TV
    Ter Arkh; 1995; 67(11):13-5. PubMed ID: 8571239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.